Content
Doctor-trusted hair loss treatments

Key Takeaways:
1mg oral finasteride effectively treats hair loss and is the standard dose for male pattern baldness.
5mg oral finasteride is for prostate issues, not hair loss.
Higher doses don’t improve hair loss results and may increase the risk of sexual side effects.
Combining oral finasteride with minoxidil can further enhance hair loss treatment results for many men.
Let’s talk 5mg finasteride vs 1mg — two different doses, one powerful hair loss treatment.
Finasteride is an oral medication that’s used to treat and prevent male pattern baldness. It was approved by the Food and Drug Administration (FDA) back in 1992 to treat benign prostatic hyperplasia, and in 1997, it was also approved to fight hair loss.
Finasteride is one of two medications (minoxidil (Rogaine®) is the other) proven to help men maintain their hair. Using finasteride may also help you regrow hair.
So what’s the difference between finasteride 1mg and finasteride 5mg, and which dose is right for you? Read on to find out how they work, when to use them, and which dose makes the most sense for you.
Content

Before we get into the nitty-gritty of how these two common finasteride doses compare, here’s a quick look at what makes them unique.
1mg finasteride | 5mg finasteride | |
|---|---|---|
Available from hims | Yes | No |
How it works | Hair loss in men, male pattern baldness (androgenetic alopecia) | Enlarged prostate |
Effectiveness | Impairs 5-alpha reductase activity to reduce DHT levels, stop male pattern baldness, and encourage hair regrowth | Causes prostate shrinkage to improve the flow of urine |
Common side effects | Helpful for most men looking to maintain and regrow hair (especially when paired with minoxidil) | Helpful for most men experiencing urinary symptoms due to enlarged prostate |
When to expect results | Minimal risk of sexual side effects | Greater chance of sexual side effects |
Finasteride is in a class of medications called 5-alpha reductase inhibitors, or 5α-reductase inhibitors. They work by inhibiting the effects of an enzyme known as 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for male pattern hair loss.
5-alpha reductase blockers reduce DHT levels, slowing down, stopping, or reversing the effects of male pattern baldness. They can also encourage hair regrowth and increase hair count.
Research shows that a typical dose of finasteride reduces DHT levels in your blood by as much as 70 percent compared with a placebo.
It can also reduce DHT levels by 90 percent in your prostate gland, which can effectively treat androgenic alopecia and an enlarged prostate.
The typical finasteride dose for hair loss is 1mg per day, but your healthcare provider will decide what’s best for you. Most hair loss treatments containing finasteride use this dose, including the original 1mg Propecia tablets.
Research backs this up. In one study, 80 percent of men saw improvements after using 1mg finasteride for 12 months to treat male pattern hair loss.
Another older study found that 83 percent of men maintained their hair after two years on 1mg finasteride compared to just 28 percent on a placebo.
But here's the thing: More finasteride isn’t necessarily better. For hair loss, 1mg of finasteride per day is enough. Taking more won’t improve results and could increase your risk of side effects.
When should men consider a higher dose of finasteride? While the 1mg dose of finasteride is effective for hair loss treatment, the 5mg dose targets prostate-related issues.
Typically, doctors prescribe the 5mg dose to treat benign prostatic hyperplasia (BPH) or enlarged prostate.
BPH is a non-cancerous condition that can make urination difficult due to prostate enlargement pressing against the urethra. Nearly all men will eventually experience BPH at some point in their lives.
The 5mg finasteride dose for BPH, often sold under the brand name Proscar®, helps control prostate growth and ease BPH symptoms, like trouble urinating.
Remember, this dose of finasteride is not for hair loss.
Finasteride is generally safe and doesn’t interact with other drugs. However, like all prescription medications, it can have potential side effects.
Fortunately, less than two percent of men report these issues, suggesting a low overall risk.
Possible adverse events include:
Skin rashes
Fatigue
Dizziness
Headaches
Swelling in the lips and face
Breast swelling or nipple discharge
The most common side effects are sexual health-related, like decreased libido, erectile dysfunction (ED), and ejaculation disorder.
Here’s how these possible sexual side effects vary based on dose:
Potential side effects of finasteride at a 1mg dose include:
Decreased sex drive
Serious side effects from finasteride treatment are highly uncommon, especially with the smaller dose. And decreased libido — the most common side effect of finasteride — only affects 1.8 percent of men who take it.
Compared to the 1mg dose, finasteride 5mg has a few more noticeable side effects.
In clinical trials, eight percent of men on finasteride 5mg experienced ED, six percent of men reported reduced interest in sex, and just under four percent noticed decreased ejaculation volume.
Other side effects reported by men using finasteride 5mg include:
Rash
Breast tissue enlargement
Breast tissue tenderness
While discontinuation of both lower and higher doses of finasteride due to sexual dysfunction is rare, it does happen.
Finasteride has been shown to lower the overall risk of prostate cancer. However, some old research from 1993 suggested it might increase the risk of high-grade prostate cancer. These earlier findings are now believed to be due to detection bias and other factors.
Today, the scientific consensus is that finasteride is a safe hair loss treatment for most men. A 2019 study involving 10,000 participants found no link between finasteride and an elevated risk of prostate cancer.
For more details on finasteride’s side effects and guidance on what to do if you experience any, check out our full guide to the side effects of finasteride.
Finasteride is also available as a topical medication that you apply directly to your hair and scalp.
Topical finasteride isn’t yet FDA-approved, but scientists are working on it. Possible side effects include skin irritation, sexual and psychological impacts, and the risk of exposure to others (particularly pregnant people).
Read more about topical finasteride.
If you’re tackling hair loss, your provider will prescribe you 1mg of oral finasteride daily — it’s effective for maintaining and regrowing hair. For men with prostate concerns, 5mg finasteride is the typical dose doctors prescribe.
When you’re ready to connect with a licensed healthcare provider to talk through your hair loss treatment options, take our free online quiz to get started.
Yes. Finasteride often works best when combined with other hair restoration treatments like minoxidil (Rogaine®) or low-level laser therapy. Using multiple approaches can improve results and help you maintain long-term hair density.
Most men notice reduced shedding in three to six months and visible regrowth after six to 12 months of consistent use.
If you discontinue treatment, DHT levels return to normal, and hair loss typically resumes within three to six months.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at blog@forhims.com!
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Dr. Beasley is licensed in all 50 states
Fellow, American Academy of Dermatology
Hair Loss, Dermatology
10 years of clinical practice as a Dermatologist
Medical Director - YouHealth Medical Groups, 2025–
Private practice, 2024–
Chief of Dermatology - , 2015–2019
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977.
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152.
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147.
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j.
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb.
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115.
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143.
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26.
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html
Dr. Beasley began doing telemedicine while serving in the U.S. Army, providing dermatologic care for soldiers stationed around the world. This experience sparked his passion for telemedicine and inspired his commitment to expanding access to healthcare for patients across the United States.
In his free time, Dr. Beasley enjoys cooking, reading, and trips to the beach with his wife and two kids (with sunscreen of course).
Hair Loss
Male Pattern Baldness
Dandruff
Scarring Alopecia
Seborrheic Dermatitis